Showing results (2211-2220 of 2,380) with videos related to

Sort By:
Pageof 238
Diagnostic Microbiology and Infectious Disease|March 16, 2010
Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimensElizabeth Wulff-Burchfield, Wiley A Schell, Allen E Eckhardt, et al.
Neuro-Oncology|July 22, 2022
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patientsRichard Drexler, Ulrich Schüller, Alicia Eckhardt, et al.
Life Science Alliance|December 10, 2025
A step-by-step guide to performing cancer metabolism research using custom-made mediaSophie Seifert, Francisco Yanqui-Rivera, Tim Kühn, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|October 22, 2019
Induced cardiac progenitor cells repopulate decellularized mouse heart scaffolds and differentiate to generate cardiac tissueRuben A Alexanian, Kaushiki Mahapatra, Di Lang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumorsMichele Basche, Daniel L Gustafson, Scott N Holden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumorsS G Diab, S D Baker, A Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignanciesLillian L Siu, Eric K Rowinsky, Lisa A Hammond, et al.
The Journal of Cardiovascular Nursing|June 17, 2016
A Pilot Randomized Controlled Trial of the Feasibility of a Multicomponent Delirium Prevention Intervention Versus Usual Care in Acute StrokeKaren L Rice, Marsha J Bennett, Linley Berger, et al.
British Journal of Cancer|July 23, 2013
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant modelJ J Arcaroli, K S Quackenbush, A Purkey, et al.
Clinical Pharmacokinetics|November 18, 2025
TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)Marian Klose, Ilaria Colombo, Katrin Gobat, et al.
Pageof 238